Mir-302c mediates influenza A virus-induced IFNβ expression by targeting NF-κB inducing kinase

FEBS Letters

Volumn 589, Issue 24, 2015, Pages 4112-4118

  Gui, Shulin ^a   Chen, Xueyuan ^a   Zhang, Mo ^a   Zhao, Fanpeng ^a   Wan, Yushun ^a   Wang, Li ^a   Xu, Gang ^a   Zhou, Li ^a   Yue, Xin ^b   Zhu, Ying ^a   Liu, Shi ^a  

^a WUHAN UNIVERSITY   (China)

^b Children's Hospital of Wuhan   (China)

Author keywords

Influenza A virus; Innate immune; MiR 302c; NF B inducing kinase; Type I IFN

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; LUCIFERASE; MICRORNA; MICRORNA 302C; MICRORNA 520E; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRF3 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; MESSENGER RNA; MIRN302 MICRORNA, HUMAN; MIRN520 MICRORNA, HUMAN; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE;

3' UNTRANSLATED REGION; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA A VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; ACTIVE TRANSPORT; AGONISTS; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DNA RESPONSIVE ELEMENT; ENZYME REPRESSION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); INNATE IMMUNITY; METABOLISM; MUCOSAL IMMUNITY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; TUMOR CELL LINE; VIROLOGY;

3' UNTRANSLATED REGIONS; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; ENZYME REPRESSION; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; MICRORNAS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RESPIRATORY MUCOSA; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84959511324     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.11.011     Document Type: Article

References (28)

1. J.K. Taubenberger, D.M. Morens, The pathology of influenza virus infections. Annu. Rev. Pathol., 3, (2008), 499-522.
2. E. Teran-Cabanillas, M. Montalvo-Corral, E. Silva-Campa, G. Caire-Juvera, S.Y. Moya-Camarena, J. Hernandez, Production of interferon alpha and beta, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1. Clin. Nutr., 33, (2014), 922-926.
3. M.S. Hayden, S. Ghosh, Shared principles in NF-kappaB signaling. Cell, 132, (2008), 344-362.
4. S.C. Sun, The noncanonical NF-kappaB pathway. Immunol. Rev., 246, (2012), 125-140.
5. F. Rapino, B.A. Abhari, M. Jung, S. Fulda, NIK is required for NF-kappaB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways. Cell Death Dis., 6, (2015), e1692 -
6. A. Oeckinghaus, M.S. Hayden, S. Ghosh, Crosstalk in NF-kappaB signaling pathways. Nat. Immunol., 12, (2011), 695-708.
7. E.M. Cherry, D.W. Lee, J.U. Jung, R. Sitcheran, Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-kappaB-inducing kinase (NIK) and noncanonical NF-kappaB signaling. Mol. Cancer, 14, (2015), 9 -
8. M. Xu, B. Skaug, W. Zeng, Z.J. Chen, A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol. Cell, 36, (2009), 302-314.
9. B.J. Zarnegar, Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol., 9, (2008), 1371-1378.
10. S. Vallabhapurapu, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol., 9, (2008), 1364-1370.
11. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, (2004), 281-297.
12. L. Song, H. Liu, S. Gao, W. Jiang, W. Huang, Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J. Virol., 84, (2010), 8849-8860.
13. X. Zhang, C. Dong, X. Sun, Z. Li, M. Zhang, Z. Guan, M. Duan, Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA. Biochem. Biophys. Res. Commun., 450, (2014), 755-761.
14. J. Fang, Q. Hao, L. Liu, Y. Li, J. Wu, X. Huo, Y. Zhu, Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J. Virol., 86, (2012), 1010-1020.
15. Y.M. Thu, A. Richmond, NF-kappaB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev., 21, (2010), 213-226.
16. R.P. Wang, M. Zhang, Y. Li, F.C. Diao, D. Chen, Z. Zhai, H.B. Shu, Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK. Mol. Immunol., 45, (2008), 1926-1934.
17. S. Liu, Q. Hao, N. Peng, X. Yue, Y. Wang, Y. Chen, J. Wu, Y. Zhu, Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology, 56, (2012), 57-66.
18. S. Zhang, C. Shan, G. Kong, Y. Du, L. Ye, X. Zhang, MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene, 31, (2012), 3607-3620.
19. S. Liu, Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways. J. Hepatol., 62, (2015), 1015-1023.
20. B. Zhong, The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity, 29, (2008), 538-550.
21. G. Liu, H.S. Park, H.M. Pyo, Q. Liu, Y. Zhou, Influenza A virus panhandle structure is directly involved in RIG-I activation and interferon induction. J. Virol., 89, (2015), 6067-6079.
22. R. Le Goffic, J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, M. Si-Tahar, Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol., 178, (2007), 3368-3372.
23. K. Zhu, MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Carcinogenesis, 34, (2013), 2071-2079.
24. K. Zhu, MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Sci. Rep., 4, (2014), 5524 -
25. D. Min, X.B. Lv, X. Wang, B. Zhang, W. Meng, F. Yu, H. Hu, Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Br. J. Cancer, 109, (2013), 723-730.
26. S.C. Sun, Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling. Sci. Signal., 3, (2010), pe18 -
27. B. Zarnegar, S. Yamazaki, J.Q. He, G. Cheng, Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U.S.A., 105, (2008), 3503-3508.
28. L. Liu, Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J. Biol. Chem., 287, (2012), 11899-11910.